Company intelligence / Profile preview

Atopis

Auckland, Auckland, New Zealand

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Atopis is a New Zealand-based biotechnology company specializing in scientifically-backed skincare solutions derived from botanical fermentation. Founded by Dr. Iona Weir, the company utilizes its patented Myrecil platform to create products that modulate the skin microbiome and immune response. Their portfolio targets common dermatological conditions such as acne, eczema, and rosacea, as well as anti-aging. Atopis emphasizes a nature-meets-science approach, leveraging clinical research to validate the efficacy of its topical treatments.

Therapeutic areas: OtherDermatology
Modalities: Botanical extractTopical
Industry: Biotech

Beyond the preview

Go deeper on Atopis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atopis.

Explore the full profile